Bone fragility fractures are caused by low bone mass or impaired bone quality. Osteoblast/osteoclast coordination determines bone mass, but the factors that control bone quality are poorly understood. Osteocytes regulate osteoblast and osteoclast activity on bone surfaces but can also directly reorganize the bone matrix to improve bone quality through perilacunar/canalicular remodeling; however, the molecular mechanisms remain unclear. We previously found that deleting the transcriptional regulators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-motif (TAZ) from osteoblast-lineage cells caused lethality in mice due to skeletal fragility. Here, we tested the hypothesis that YAP and TAZ regulate osteocyte-mediated bone remodeling by conditional ablation of both YAP and TAZ from mouse osteocytes using 8 kb-DMP1-Cre. Osteocyte-conditional YAP/TAZ deletion reduced bone mass and dysregulated matrix collagen content and organization, which together decreased bone mechanical properties. Further, YAP/TAZ deletion impaired osteocyte perilacunar/canalicular remodeling by reducing canalicular network density, length, and branching, as well as perilacunar flourochrome-labeled mineral deposition. Consistent with recent studies identifying TGF-β as a key inducer of osteocyte expression of matrix-remodeling enzymes, YAP/TAZ deletion in vivo decreased osteocyte expression of matrix proteases MMP13, MMP14, and CTSK. In vitro, pharmacologic inhibition of YAP/TAZ transcriptional activity in osteocyte-like cells abrogated TGF-β-induced matrix protease gene expression. Together, these data show that YAP and TAZ control bone matrix accrual, organization, and mechanical properties by regulating osteocyte-mediated bone remodeling. Elucidating the signaling pathways that control perilacunar/canalicular remodeling may enable future therapeutic targeting of bone quality to reverse skeletal fragility.

No abstract

The interaction of nanoparticles (NPs) with pulmonary surfactant is important for understanding the potential adverse effects of inhaled engineered and incidental nanomaterials. The effects of a low concentration (0.001 wt %) of charged, hydrophilic silica NPs of hydrodynamic diameter of ∼20 nm on the phase behavior and lateral structure of lipid-only and naturally derived surfactant monolayers were investigated at the air/water interface using surface pressure–area isotherms and Brewster angle microscopy, respectively. Atomic force microscopy was used to image the morphology of films transferred onto mica substrate with nanometer resolution. We show that the silica NPs can significantly alter the condensed domain size and shape even in the absence of apparent differences in the monolayer compression isotherms. The cationic particles notably induce structural and morphological progressions in a binary model containing anionic phosphoglycerol that are similar to those observed for the natural surfactant film that contains cationic proteins. These findings specifically highlight the impact of the NP charge on the phase transformations in pulmonary surfactant, with implications for the engineering of nanomaterials for commercial use and bioapplications.

No abstract

Highlights Machine learning approaches allow for the simultaneous analysis to an entire microCT dataset to minimize bias and demonstrated that collective microarchitectural changes. K-Means clusters and Support Vector Machine classification visualization provide intuitive interpretations of the differences in bone structure and microarchitecture between groups. These techniques are complimentary to common statistical testing and provide additional ways of showing differences between microCT outcomes.